Eli Lilly & Co. increased sales of the weight-loss and diabetes drug Mounjaro 60% in India in May from April in its second ...

Wall Street gains as S&P 500 surpasses 6,000; key healthcare stock movers revealed. Explore top deals, trends, and regulatory updates in the sector.

Eli Lilly's weight-loss and diabetes drug Mounjaro, has seen sales in India jump 60 per cent between April and May. The ...

Eli Lilly's weight-loss and diabetes drug, Mounjaro, has rapidly gained popularity in India, achieving Rs 24 crore in sales ...

The presence of multinational pharma companies (MNCs) in India's drug market continues to shrink, reaching 14.5% in May 2025 ...

The Japanese biotech behind Eli Lilly’s new blockbuster obesity pill believes it could be used with an anti-muscle wasting drug it has developed to create a new standard of patient care for weight ...

Recent health news highlights include a halt in new measles cases in Texas, efforts to accelerate the approval of drugs for ...

Experts suggest that weight-loss jabs may require long-term use to achieve lasting benefits for both patients and the NHS.

Off-price retail stocks have had a good week, and Five Below Inc. (NASDAQ: FIVE) was no exception. After the market closed on ...

Wealth Enhancement Advisory Services LLC raised its holdings in Nuveen Churchill Direct Lending Corp. (NYSE:NCDL – Free Report) by 54.7% during the fourth quarter, according to its most recent ...

Hennion & Walsh Asset Management Inc. lifted its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 66.0% during the 1st quarter, according to the company in its most recent filing ...

Novo Nordisk Thailand has signed an MoU with HSRI – and the Health Systems Research Institute  – to strengthen Thailand’s clinical research infrastructure and foster healthcare innovation. The ...